Shape the future of immunotherapy research:
Join our patient survey today!

Click to get started:

English survey:  https://forms.office.com/e/FhykHux156   

Spanish survey: https://forms.office.com/e/VdKgwxLkZ6  

Your voice matters! Take a few minutes to participate in our brief survey and share your thoughts on immunotherapy. Let us know what information matters to you most and the challenges you face in accessing treatments. Your insights will help shape the future of immunotherapy research and healthcare delivery in follicular lymphoma. 

The survey is live for 2 weeks only, from 22 May – 5 June, 2024. 

Don’t miss this opportunity to make a meaningful difference!  

What is immunotherapy?

Immunotherapy stands at the forefront of cancer treatment and offers a revolutionary opportunity to harness the body’s immune system to target cancerous cells, learn more here​.

Dr Mitchell Smith, FLF’s Chief Medical Officer, explains more about the latest advancements in immunotherapy treatments, including CAR-T cells and bi-specific antibodies, and why your voice matters.